Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameC-Mer Medical
Stock Code03309
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們是香港及廣東省領先的眼科服務提供商之一,提供白內障、眼角膜與眼表疾病、青光眼、玻璃體視網膜及黃斑疾病等眼科疾病的診斷與治療服務,以及針灸及中醫輔助治療眼疾。
Listing Date2018-01-15
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)香港畢打街1-3號中建大廈1535室
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitecmereye.com
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 2.90 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer Period2017-12-29 to 2018-01-08
Global Offering Shares197,000,000 shares
HK Public Offer Shares (Initial)19,700,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)177,300,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO1,000,000,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share36.0%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 571,300,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
HK Market Cap HK$ 1.33B
Est. Threshold HK$ 9.44B
Analysis Result HK market cap below threshold, need +611%

Valuation & Financials

Market Cap (at Offer Price)HK$ 2,630,000,000
Pre-IPO Valuation (Last Round)約1,700百萬港元
P/E RatioNot disclosed
Profit/Loss Status2016年盈利約46.9百萬港元
Period-End Cash BalanceTo be extracted
Listing Expenses~HK$ 50,000,000
Listing Expenses / Funds Raised~8.75%
Total Pre-IPO Investment142.0百萬港元

Financial Data

Unit: '000 HKD
Income Statement
Item 2014201520162017-06
Revenue 156,472198,851248,659140,449
Cost of sales -97,429-119,150-153,683-77,755
Gross profit 59,04379,70194,97662,694
Other income and gains, net 2015471,497678
Selling and distribution expenses -2,918-4,694-7,874-4,235
Administrative expenses -27,676-26,454-30,534-24,806
Operating profit 28,92949,62059,52834,617
Net finance costs -966-1,189-932-334
Profit before tax 27,96348,43158,59634,283
Income tax expense -5,602-10,074-11,709-8,927
Profit for the year 22,36138,35746,88725,356
Profit attributable to owners 22,36138,35746,88725,356
Balance Sheet
Item 2014201520162017-06
Cash and cash equivalents 11,24623,34858,760182,229
Trade and bills receivables 1,7453,4644,4566,095
Inventories 2,0211,5072,3282,366
Total current assets 52,91990,55185,890244,222
Total assets 102,817132,375128,642311,728
Total current liabilities 64,73358,46464,02475,888
Total liabilities 72,00465,42765,21076,820
Total equity 30,81366,94863,432234,908
Equity attributable to owners 30,81366,94863,432234,908
Interest-bearing borrowings 43,88433,31018,52319,502
Cash Flow Statement
Item 2014201520162017-06
Net cash from operating activities 42,60650,54553,49734,425
Net cash from investing activities -28,372-25,739-13,821-47,856
Net cash from financing activities -6,112-13,007-3,048135,698
Net increase in cash 8,12211,79936,628122,267
Purchase of PP&E -7,342-2,699-11,247-1,869
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 5.11
First Day OpenHK$ 5.35
First Day Change76.21%
First Day Volume211598000.0
First Day Turnover1120740000.0
Use of Proceeds
1、221.6百萬港元(或42.5%)用于對選定中國城市三間運營中眼科醫院的潛在收購; 2、210.6百萬港元(或40.4%)用于在選定的中國城市開設三間眼科醫院; 3、21.9百萬港元(或4.2%)用于在中國深圳開設兩間衛星診所; 4、44.3百萬港元(或8.5%)用于升級我們的醫療設備及強化我們在香港及中國的信息科技系統; 5、22.9百萬港元(或4.4%)用于我們的營運資金及一般企業用途。

Underwriting Syndicate

Sole Sponsor (1)
CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650
Overall Coordinators (1)
CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650
Joint Bookrunners (1)
CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Advance Data Services Limited 68,805,400 HKD — 12.00% — 6 months 2018-07-15
2 Gunther Group Limited 68,805,400 HKD — 12.00% — 6 months 2018-07-15
3 香港华丽有限公司 68,805,400 HKD — 12.00% — 6 months 2018-07-15

Directors & Management

PositionChinese nameEnglish Name
Chairman林順潮—
Company Secretary陳華平—
No director data available.

Major Shareholders

Major Shareholders & Holdings希瑪集團、林順潮及李肖婷為控股股東;緊隨全球發售及資本化發行完成後,希瑪集團持有722,696,756股股份,佔72.3%。
About this page

This page shows C-Mer Medical (03309) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect